Hosted on MSN5mon
QIAGEN's (QGEN) New Launch Expands US Syndromic Testing Menu
QIAGEN N.V. QGEN announced the launch of QIAstat-Dx Gastrointestinal Panel 2 in the United States following the recent FDA clearance of the syndromic test for use in clinical settings.
Blood tests for colon cancer screening not ready to replace colonoscopy, study indicates
New blood tests screen for colorectal cancer in a much less invasive way than colonoscopy, but deaths will increase if many ...
Biomerica Announces Direct-to-Consumer Availability of inFoods® IBS Test, Targeting Relief for Bloating and Gastrointestinal Pain
Patients experiencing bloating and gastrointestinal discomfort can now order inFoods® IBS directly from without needing to ...
Medscape1mon
Limited Role of Allergy Testing in Patients With Eosinophilic Gastrointestinal Disorders
Background and Aim Allergies have been implicated in the pathogenesis of eosinophilic gastrointestinal disorders ... with a multiple antigen simultaneous test 33 (MAST33). The expression patterns ...
Yahoo Finance6d
Biomerica Announces Direct-to-Consumer Availability of inFoods® IBS Test, Targeting Relief for Bloating and Gastrointestinal Pain
The InFoods IBS test provides a breakthrough tool for individuals with Irritable Bowel Syndrome (IBS) who seek to manage symptoms such as bloating and gastrointestinal pain. The inFoods ® IBS ...